Dr. Janice Faulknor is a 15-year veteran in clinical research on CNS products, Human Abuse Potential (HAP) and Abuse Deterrent Assessment programs. Having conducted over 100+ Phase1/HAL trials over her 8-year tenure as PI/Sub-I with BioPharma Services, Dr. Faulknor is an industry leader, and a key member of the BPSI medical team. Dr. Faulknor gained her medical degree from the McMaster University in 1996 with a specialty in Family Medicine and continues to practise today.
Recent Posts
- Data Management & Clinical Trial Biostatistics – Standalone Backend Services
- Foreign Trained Professionals; the Unsung Heroes of the CRO Industry
- Debunking the Top 4 Most Common Myths About Clinical Trials
- Eight Reasons to Choose Canada for Your Phase 1 Clinical Trial
- Leveraging the 505(b)(2) Program to Prolong the Life of a New Chemical Entity (NCE)
Recent Comments